Legendary stress and pain relief within your reach
Over the past few decades, one of the most debated topics of all time is the health benefits of the cannabis plant.
The facts have been revealed, with cannabis myths and legends now being backed by science. Adcock Ingram (Pty) Ltd, a leading pharmaceutical company, is pleased to announce the launch of its flagship cannabis-based range, ADCO CBD, in South Africa.
CBD stands for cannabidiol, a compound found in the cannabis plant which researchers have been studying for possible therapeutic use.¹
The ADCO CBD range has been formulated using cannabidiol isolate2, processed from the cannabis raw plant, in line with the recent Government Gazette which permits CBD preparations to contain a maximum daily dose of 20 mg CBD.3
CBD may assist with the relief of minor pain and symptoms associated with stress. CBD may well help to ease inflammatory-, tissue-, muscle-, joint- and neuropathic pain.4 It has also been shown to provide relief to those experiencing anxiety, muscular tension, restlessness, fatigue and poor concentration.5
To this end, Adcock Ingram is thrilled to launch ADCO CBD PAIN available in drops (15 ml and 30 ml), capsule and gel format (50 g), ADCO CBD STRESS available in drops (15 ml and 30 ml) and capsule format and ADCO CBD DAILY available in drops (15 ml and 30 ml) and capsule format.
Products are laboratory tested, quality controlled, and do not contain sugar or tartrazine.
References: 1 VanDolah Clinicians guide to CBD and hemp oils 2 ADCO CBD Trade Presenter 3. Department of Health, Government Gazette. Regulation Gazette No. 10949; 23 May 2019, vol. 647, no. 42477. 4. Mbvundula EC, Rainsford KD, Bunning AD. Cannabinoids in pain and inflammation. Inflammopharmacology 2004;12(2):99-114. 5. Pisanti S, Malfitano AM, Ciaglia E, et al. Cannabidiol: State of the art and new challenges for therapeutic applications. Pharmacol Ther 2017;175:133-150.